Benjamin M. Solomon logo Avera Cancer Institute logo

Benjamin M. Solomon

Medical Oncologist, Avera Cancer Institute (USA)


Dr. Benjamin Solomon, M.D, is a medical oncologist at Avera Cancer Institute and Associate Professor of Medicine at USD Sanford School of Medicine, in Sioux Falls, South Dakota.

Dr. Solomon holds two administrative directorships as the Medical Information Officer and the Oncology Clinical Research Officer at Avera. He graduated from University of Nebraska Medical Center prior to completing residency in internal medicine and fellowship in medical oncology and hematology at Mayo Clinic, in Rochester, MN. His clinical practice focuses on diagnosis and management of patients with solid tumors with a special focus in head/neck and thoracic malignancies.

Dr. Solomon’s research focuses on clinical trials research as well as applied precision oncology and cellular therapy approaches to the treatment of cancers of the lung and head/neck.


Why WIN

The WIN Consortium facilitates a much needed collaborative relationship between many worldwide member institutions, which can leverage their individual strengths to serve the common good of advancing research in precision oncology.

Benjamin M. Solomon logo

Benjamin M. Solomon

Medical Oncologist, Avera Cancer Institute (USA)


Avera Cancer Institute logo

Dr. Benjamin Solomon, M.D, is a medical oncologist at Avera Cancer Institute and Associate Professor of Medicine at USD Sanford School of Medicine, in Sioux Falls, South Dakota.

Dr. Solomon holds two administrative directorships as the Medical Information Officer and the Oncology Clinical Research Officer at Avera. He graduated from University of Nebraska Medical Center prior to completing residency in internal medicine and fellowship in medical oncology and hematology at Mayo Clinic, in Rochester, MN. His clinical practice focuses on diagnosis and management of patients with solid tumors with a special focus in head/neck and thoracic malignancies.

Dr. Solomon’s research focuses on clinical trials research as well as applied precision oncology and cellular therapy approaches to the treatment of cancers of the lung and head/neck.


Why WIN

The WIN Consortium facilitates a much needed collaborative relationship between many worldwide member institutions, which can leverage their individual strengths to serve the common good of advancing research in precision oncology.